Invitrogen Corporation
5791 Van Allen Way
P.O. Box 6482
Carlsbad
California
92008
United States
Tel: 760-603-7200
Fax: 760-602-6500
Website: http://www.invitrogen.com/
About Invitrogen Corporation
Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions as well as pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery, including functional genomics, proteomics, bioinformatics and cell biology - placing Invitrogen's products in nearly every major laboratory in the world.
Founded in 1987, Invitrogen is celebrating 20 years of accelerating scientific discovery. The company is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. Invitrogen globally employs approximately 4,300 scientists and other professionals and had revenues of more than $1.3 billion in 2007. Invitrogen has eight manufacturing locations in North America, Europe and Asia, operations in more than 20 countries, and distributor relationships in 70 countries worldwide.
Corporate Management:
Business Units:
Functional Genomics, Drug Discovery Solutions, Detection Technologies, BioProduction, Cell Culture, Biological Defense Systems
224 articles about Invitrogen Corporation
-
Massachusetts in general and Boston, specifically Cambridge, is one of the two largest centers in the U.S. for biotech startups and life science companies (the other being the San Francisco Bay Area). Here’s a look at 13 Massachusetts life science companies that are showing both gains and losses—...
-
Celsis In Vitro Technologies Seeks Injunction Against Invitrogen Corporation for LiverPool(TM) Patent Infringement
7/1/2010
-
Invitrogen Corporation Launches Biomarker Tool for Pre-Clinical Research into Kidney Function
7/30/2009
-
Invitrogen Corporation Launches Life Science Industry's First Complete Resource for Cellular Technologies and Education
7/7/2009
-
Invitrogen Corporation Launches New Microarray System to Simplify Immunogenetic Testing
6/29/2009
-
Invitrogen Corporation Scientists Compile Comprehensive Guidebooks for Stem Cell Research
5/21/2009
-
Invitrogen Corporation Launches Enriched Online Retail Experience for Its Award-Winning Website
5/20/2009
-
Invitrogen Corporation Develops New Technology to Promote Safer Stem Cell Therapies
5/4/2009
-
Invitrogen Corporation Launches Next-Generation Cell Culture Solution for Immunology Research
4/13/2009
-
Invitrogen Corporation Introduces Innovation that Speeds Regulatory Filings and Time to Market for Biotherapeutics Manufacturers
4/1/2009
-
Invitrogen Corporation Launches Benchtop Device That Simplifies Primary and Stem Cell Research
3/24/2009
-
Invitrogen Corporation Earns AmeriStar Award for GIBCO Cell Culture Bottle Design
2/26/2009
-
Invitrogen Corporation Launches Benchtop Device That Simplifies Protein Analysis Workflows
1/21/2009
-
Invitrogen Corporation Receives Approval from Health Canada for System to Help Determine Organ Transplant Compatibility
1/13/2009
-
Invitrogen Corporation Release: Life Technologies Corporation's Solutions Enable Tissue-Engineered Transplant
12/22/2008
-
Invitrogen Corporation Launches Solutions to Simplify DNA and RNA Workflows on Next-Generation Sequencing Systems
12/18/2008
-
Life Technologies Corporation Announces Final Results of Election Regarding Invitrogen Corporation and Applied Biosystems Merger Consideration
12/1/2008
-
Invitrogen Corporation And Applied Biosystems Complete Merger
11/21/2008
-
Invitrogen Corporation Launches In Vivo RNAi Delivery Reagent
11/20/2008
-
Invitrogen Corporation And Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration
11/20/2008